Risk profiling of patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) by measuring circulating tumor DNA (ctDNA): 3-year update of the POLARIX study Meeting Abstract


Authors: Oellerich, T.; Lenz, G.; Herrera, A. F.; McCord, R.; Kimes, P.; Jardin, F.; Trnény, M.; Flowers, C. R.; Sehn, L. H.; Salles, G.; Sharman, J. P.; Tilly, H.; Friedberg, J. W.; Herbaux, C.; Matasar, M.; Haioun, C.; Tracy, S.; Hirata, J.; Lee, C.; Jiang, Y.; Morschhauser, F.
Abstract Title: Risk profiling of patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) by measuring circulating tumor DNA (ctDNA): 3-year update of the POLARIX study
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (2023)
Journal Title: Oncology Research and Treatment
Volume: 46
Issue: Suppl. 5
Meeting Dates: 2023 Oct 13-16
Meeting Location: Hamburg, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2023-10-01
Start Page: 24
End Page: 25
Language: English
ACCESSION: WOS:001091456900047
PROVIDER: wos
PUBMED: 37788643
DOI: 10.1159/000533576
Notes: Meeting Abstract: V105 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gilles Andre Salles
    269 Salles